100(top 2%)
PR articles
38.3K(top 0.1%)
PR citations
40(top 1%)
PR h-index
42(top 1%)
h-index
117
documents
46.5K
doc citations
5.5K
citing journals
100
times ranked

Publications

100 peer-reviewed articles • 40,677 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Antithrombotic therapy for secondary Stroke prevention in patients with symptomatic large artery atherosclerosis and atrial fibrillation (FIB-CAS study) A single-center experience
Journal of the Neurological Sciences, 2025, 468, 123352
2.13Citations (PDF)
2Maternal coronary heart disease and mortality following hypertensive disorders of pregnancy and/or diabetes
Cardiovascular Diabetology, 2025, 24,
9.41Citations (PDF)
3Optimal Medical Management of Atherosclerotic Intracranial Stenosis
Stroke, 2024, 55, 335-343
5.915Citations (PDF)
4Hypertensive Disorders of Pregnancy and Pre-Pregnancy Hypertension with Subsequent Incident Venous Thromboembolic Events
International Journal of Environmental Research and Public Health, 2024, 21, 89
2.96Citations (PDF)
5Pathology-based brain arterial disease phenotypes and their radiographic correlates
Journal of Stroke and Cerebrovascular Diseases, 2024, 33, 107642
1.610Citations (PDF)
6The Association of Hypertensive Disorders of Pregnancy with Infant Mortality, Preterm Delivery, and Small for Gestational Age
Healthcare (Switzerland), 2024, 12, 597
2.18Citations (PDF)
7Adapting to Evolving Technologies and Treatment Guidelines in a Procedural Trial
Neurology, 2023, 100, 1060-1066
1.03Citations (PDF)
8Change in Smoking Behavior and Outcome After Ischemic Stroke: Post-Hoc Analysis of the SPS3 Trial
Stroke, 2023, 54, 921-927
5.917Citations (PDF)
9Ameliorating Racial Disparities in Vascular Risk Factor Management With Aggressive Medical Management in the SAMMPRIS Trial
Stroke, 2023, 54, 2235-2240
5.95Citations (PDF)
10Effect of dihydropyridine calcium channel blockers on blood pressure variability in the SPRINT trial: a treatment effects approach
Journal of Hypertension, 2022, 40, 462-469
2.125Citations (PDF)
11Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment
Lancet Neurology, The, 2022, 21, 355-368
17.9300Citations (PDF)
12Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory
Neurology, 2022, 98, 486-498
1.088Citations (PDF)
13Long-Term Secondary Prevention: Management of Blood Pressure After a Transient Ischemic Attack or Stroke
Stroke, 2022, 53, 1085-1103
5.925Citations (PDF)
14Hypertensive Disorders of Pregnancy With and Without Prepregnancy Hypertension Are Associated With Incident Maternal Kidney Disease Subsequent to Delivery
Hypertension, 2022, 79, 844-854
6.66Citations (PDF)
15Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
Neurology, 2021, 96,
1.0119Citations (PDF)
16Maternal Coronary Heart Disease, Stroke, and Mortality Within 1, 3, and 5 Years of Delivery Among Women With Hypertensive Disorders of Pregnancy and Pre‐Pregnancy Hypertension
Journal of the American Heart Association, 2021, 10,
4.059Citations (PDF)
17High-resolution vessel wall imaging after mechanical thrombectomy
Neuroradiology Journal, 2021, 34, 593-599
1.016Citations (PDF)
18White Matter Hyperintensity and Cardiovascular Disease Outcomes in the SPRINT MIND Trial
Journal of Stroke and Cerebrovascular Diseases, 2021, 30, 105764
1.615Citations (PDF)
192021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
Stroke, 2021, 52,
5.92,764Citations (PDF)
20Non-Adherence to Antihypertensive Guidelines in Patients with Asymptomatic Carotid Stenosis
Journal of Stroke and Cerebrovascular Diseases, 2021, 30, 105918
1.612Citations (PDF)
21Incident Heart Failure Within the First and Fifth Year after Delivery Among Women With Hypertensive Disorders of Pregnancy and Prepregnancy Hypertension in a Diverse Population
Journal of the American Heart Association, 2021, 10,
4.022Citations (PDF)
22Cilostazol for Secondary Stroke Prevention
Stroke, 2021, 52,
5.945Citations (PDF)
23Submaximal Angioplasty for Symptomatic Intracranial Atherosclerotic Disease: A Meta-Analysis of Peri-Procedural and Long-Term Risk
Neurosurgery, 2020, 86, 755-762
2.048Citations (PDF)
24Dual Antiplatelet Therapy Beyond 90 days in Symptomatic Intracranial Stenosis in the SAMMPRIS Trial
Journal of Stroke and Cerebrovascular Diseases, 2020, 29, 105254
1.618Citations (PDF)
25Mitigating the effects of COVID-19 pandemic on controlling vascular risk factors among participants in a carotid stenosis trial
Journal of Stroke and Cerebrovascular Diseases, 2020, 29, 105362
1.65Citations (PDF)
26Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial
Stroke, 2020, 51, 2960-2971
5.936Citations (PDF)
27The CREST-2 experience with the evolving challenges of COVID-19
Neurology, 2020, 95, 29-36
1.013Citations (PDF)
28Optimized Hemodynamic Assessment to Predict Stroke Risk in Vertebrobasilar Disease: Analysis From the VERiTAS Study
Journal of the American Heart Association, 2020, 9,
4.014Citations (PDF)
29Relationship Between Vascular Risk Factors and Location of Intracranial Atherosclerosis in the SAMMPRIS Trial
Journal of Stroke and Cerebrovascular Diseases, 2020, 29, 104713
1.611Citations (PDF)
30Secondary Stroke Prevention and Management for the Neuro-Ophthalmologist
Journal of Neuro-Ophthalmology, 2020, 40, 463-471
1.00Citations (PDF)
31Is There Equipoise Regarding the Optimal Medical Treatment of Patients with Asymptomatic White Matter Hyperintensities?
Journal of Stroke and Cerebrovascular Diseases, 2019, 28, 104371
1.62Citations (PDF)
32Type and Duration of Exercise in the SAMMPRIS Trial
Neurologist, 2019, 24, 10-12
0.96Citations (PDF)
33Hemodynamic Markers in the Anterior Circulation as Predictors of Recurrent Stroke in Patients With Intracranial Stenosis
Stroke, 2019, 50, 143-147
5.9117Citations (PDF)
34Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis Trial
Journal of Stroke and Cerebrovascular Diseases, 2018, 27, 801-805
1.619Citations (PDF)
35Development of a high resolution MRI intracranial atherosclerosis imaging phantom
Journal of NeuroInterventional Surgery, 2018, 10, 143-149
3.115Citations (PDF)
36Phentermine associated recurrent intracerebral hemorrhage
Journal of the Neurological Sciences, 2018, 393, 135-137
2.15Citations (PDF)
37Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
Hypertension, 2018, 72,
6.6975Citations (PDF)
38High-Resolution Magnetic Resonance Imaging Evidence for Intracranial Vessel Wall Inflammation Following Endovascular Thrombectomy
Journal of Stroke and Cerebrovascular Diseases, 2017, 26, e96-e98
1.69Citations (PDF)
39Postprandial Clearance of Oxidized Low-Density Lipoprotein in Patients with Stroke Due to Atherosclerosis
Journal of Stroke and Cerebrovascular Diseases, 2017, 26, 488-493
1.67Citations (PDF)
40Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis)
Stroke, 2017, 48, 1501-1506
5.982Citations (PDF)
41Relationship between risk factor control and vascular events in the SAMMPRIS trial
Neurology, 2017, 88, 379-385
1.0190Citations (PDF)
42Large Artery Atherosclerosis: Extracranial and Intracranial
Seminars in Neurology, 2017, 37, 307-315
1.710Citations (PDF)
43Symptomatic Carotid Artery Stenosis: Surgery, Stenting, or Medical Therapy?
Current Treatment Options in Cardiovascular Medicine, 2017, 19,
0.547Citations (PDF)
44Higher Stroke Risk with Lower Blood Pressure in Hemodynamic Vertebrobasilar Disease: Analysis from the VERiTAS Study
Journal of Stroke and Cerebrovascular Diseases, 2017, 26, 403-410
1.638Citations (PDF)
45Impact of the New American Heart Association/American Stroke Association Definition of Stroke on the Results of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial
Journal of Stroke and Cerebrovascular Diseases, 2017, 26, 108-115
1.68Citations (PDF)
46Heart Disease and Stroke Statistics—2016 Update
Circulation, 2016, 133,
18.05,814Citations (PDF)
47Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial
JAMA Neurology, 2016, 73, 308
17.674Citations (PDF)
48Executive Summary: Heart Disease and Stroke Statistics—2016 Update
Circulation, 2016, 133, 447-454
18.02,289Citations (PDF)
49Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis
JAMA Neurology, 2016, 73, 36
17.666Citations (PDF)
50Characterization of intracranial atherosclerotic stenosis using high‐resolution MRI study – rationale and design
Brain and Behavior, 2015, 5,
2.427Citations (PDF)
51Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial
Neurology, 2015, 85, 2090-2097
1.04Citations (PDF)
52Executive Summary: Heart Disease and Stroke Statistics—2015 Update
Circulation, 2015, 131, 434-441
18.0528Citations (PDF)
53Outcome in Patients Previously on Antithrombotic Therapy in the SAMMPRIS Trial
Stroke, 2015, 46, 775-779
5.921Citations (PDF)
54Heart Disease and Stroke Statistics—2015 Update
Circulation, 2015, 131,
18.06,268Citations (PDF)
55Practical Approach to Management of Intracranial Atherosclerosis
Current Treatment Options in Cardiovascular Medicine, 2015, 17,
0.51Citations (PDF)
56Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID?
Stroke, 2015, 46, 2562-2567
5.941Citations (PDF)
57Hemodynamic Features of Symptomatic Vertebrobasilar Disease
Stroke, 2015, 46, 1850-1856
5.960Citations (PDF)
58Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention
Circulation, 2015, 132, 1157-1213
18.0525Citations (PDF)
59Racial Differences in Poststroke Rehabilitation Utilization and Functional Outcomes
Archives of Physical Medicine and Rehabilitation, 2015, 96, 84-90.e1
1.952Citations (PDF)
60Comparison of endovascular treatment approaches for acute ischemic stroke: cost effectiveness, technical success, and clinical outcomes
Journal of NeuroInterventional Surgery, 2015, 7, 666-670
3.1140Citations (PDF)
61Heart Disease and Stroke Statistics—2014 Update
Circulation, 2014, 129,
18.04,678Citations (PDF)
62Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial
Lancet, The, 2014, 383, 333-341
62.1857Citations (PDF)
63Executive Summary: Heart Disease and Stroke Statistics—2014 Update
Circulation, 2014, 129, 399-410
18.01,375Citations (PDF)
64Intracranial atherosclerosis: Correlation between in-vivo 3T high resolution MRI and pathology
Atherosclerosis, 2014, 237, 460-463
1.583Citations (PDF)
65Treatment Trends In Management Of Intracranial Stenosis In The Pre- And Post-Sammpris Era (P1.146)
Neurology, 2014, 82,
1.00Citations (PDF)
66Treatment Trends In Management Of Intracranial Stenosis In The Pre- And Post-Sammpris Era (I8-1.008)
Neurology, 2014, 82,
1.00Citations (PDF)
67Are AHA/ASA Stroke Guidelines Evident Enough? (P4.286)
Neurology, 2014, 82,
1.00Citations (PDF)
68Association Between Lipoprotein (a) Levels and Vascular Events in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. (P1.147)
Neurology, 2014, 82,
1.00Citations (PDF)
69The Challenge of Stroke Prevention with Intracranial Arterial Stenosis
Current Cardiology Reports, 2013, 15,
2.94Citations (PDF)
70Executive Summary: Heart Disease and Stroke Statistics—2013 Update
Circulation, 2013, 127, 143-152
18.01,241Citations (PDF)
71Heart Disease and Stroke Statistics—2013 Update
Circulation, 2013, 127,
18.04,489Citations (PDF)
72High‐resolution MRI of basilar atherosclerosis: three‐dimensional acquisition and FLAIR sequences
Brain and Behavior, 2013, 3, 1-3
2.417Citations (PDF)
73Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment
Lancet Neurology, The, 2013, 12, 1106-1114
17.9439Citations (PDF)
74An Updated Definition of Stroke for the 21st Century
Stroke, 2013, 44, 2064-2089
5.93,225Citations (PDF)
75Intracranial Stenting
Stroke, 2013, 44,
5.99Citations (PDF)
76High-Resolution Magnetic Resonance Imaging
Stroke, 2013, 44, 287-292
5.9135Citations (PDF)
77Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial
Journal of NeuroInterventional Surgery, 2013, 5, 528-533
3.163Citations (PDF)
78Utilization of CT perfusion patient selection for mechanical thrombectomy irrespective of time: a comparison of functional outcomes and complications
Journal of NeuroInterventional Surgery, 2013, 5, 518-522
3.126Citations (PDF)
79Mechanisms of Stroke After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial
Neurosurgery, 2013, 72, 777-795
2.0148Citations (PDF)
80Rationale, Design, and Implementation of Aggressive Risk Factor Management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial
Circulation: Cardiovascular Quality and Outcomes, 2012, 5,
4.150Citations (PDF)
81CT perfusion-guided patient selection for endovascular treatment of acute ischemic stroke is safe and effective
Journal of NeuroInterventional Surgery, 2012, 4, 261-265
3.143Citations (PDF)
82Executive Summary: Heart Disease and Stroke Statistics—2012 Update
Circulation, 2012, 125, 188-197
18.01,234Citations (PDF)
83Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation
Stroke, 2012, 43, 3442-3453
5.9259Citations (PDF)
84Detailed Analysis of Periprocedural Strokes in Patients Undergoing Intracranial Stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS)
Stroke, 2012, 43, 2682-2688
5.9194Citations (PDF)
85REACH MUSC: A Telemedicine Facilitated Network for Stroke: Initial Operational Experience
Frontiers in Neurology, 2012, 3,
2.321Citations (PDF)
86Heart Disease and Stroke Statistics—2012 Update
Circulation, 2012, 125,
18.04,198Citations (PDF)
87Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis
New England Journal of Medicine, 2011, 365, 993-1003
34.51,869Citations (PDF)
88Heart Disease and Stroke Statistics—2011 Update
Circulation, 2011, 123,
18.04,513Citations (PDF)
89Design of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial
Journal of Stroke and Cerebrovascular Diseases, 2011, 20, 357-368
1.6117Citations (PDF)
90Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
Stroke, 2011, 42, 227-276
5.91,505Citations (PDF)
91Intraplaque Hemorrhage in Symptomatic Intracranial Atherosclerotic Disease
2011, 21, e159-e161
70Citations (PDF)
92Collaterals dramatically alter stroke risk in intracranial atherosclerosis
Annals of Neurology, 2011, 69, 963-974
6.6294Citations (PDF)
9310 Questions About Intracranial Atherosclerotic Stenosis
Neurologist, 2010, 16, 400-405
0.90Citations (PDF)
94Risk Factors Associated With Severity and Location of Intracranial Arterial Stenosis
Stroke, 2010, 41, 1636-1640
5.9120Citations (PDF)
95Failure of Antithrombotic Therapy and Risk of Stroke in Patients With Symptomatic Intracranial Stenosis
Stroke, 2009, 40, 505-509
5.957Citations (PDF)
96Treatment of Atherosclerotic Intracranial Arterial Stenosis
Stroke, 2009, 40, 2257-2261
5.945Citations (PDF)
97Relationship Between Blood Pressure and Stroke Recurrence in Patients With Intracranial Arterial Stenosis
Circulation, 2007, 115, 2969-2975
18.0163Citations (PDF)
98Clinical Characteristics of Patients With Early Hospital Arrival After Stroke Symptom Onset
Journal of Stroke and Cerebrovascular Diseases, 2005, 14, 272-277
1.623Citations (PDF)
99Posttraumatic Cerebrospinal Fluid Hypertension and Hypotension
Archives of Neurology, 2004, 61,
6.82Citations (PDF)
100Stroke in pregnancy
Neurologic Clinics, 2004, 22, 821-840
2.622Citations (PDF)